Versor Investments’s Elanco Animal Health ELAN Stock Holding History

Versor Investments’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50,000	Closed	-$714K	–	722
2025 Q2	$714K	Buy	+50,000	New	+$584K	0.13%	268
2024 Q4	–	Sell	-25,900	Closed	-$380K	–	815
2024 Q3	$380K	Buy	+25,900	New	+$361K	0.06%	510

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Versor Investments's ELAN Position: Q3 2025 in Review

Versor Investments sold out of Elanco Animal Health (ELAN) in Q3 2025, closing a stake of 50,000 shares — an estimated $714K sold.

Versor Investments first reported a position in ELAN in Q3 2024 and held it in 2 quarters. The position peaked at $714K in Q2 2025. 410 funds tracked by Wall St. Rank hold ELAN as of Q3 2025.

Versor Investments reported no remaining Elanco Animal Health position as of Q3 2025 after selling out during the quarter.
Versor Investments sold 50,000 Elanco Animal Health shares in Q3 2025, an estimated $714K.
Versor Investments first reported a position in Elanco Animal Health in Q3 2024 and held it in 2 quarters.
Versor Investments's Elanco Animal Health position peaked at $714K in Q2 2025.
410 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.